However, cisplatin plus eIF5A2 silencing treatment significantly reduced tumor volume after 15 days compared to the cisplatin alone treated mice, suggesting that eIF5A2 downregulation reinforced the anti-tumor effects of cisplatin. This evidence concerns the gene EIF5A2 and neoplasm.